Dr Robbins discusses Atherothrombosis with a Focus on PAD
Goal and Objective
After participating in this activity, the viewer should be better able to: 1. Describe atherothrombosis manifestations and mortality rates 2. Identify physical exam findings and risk factors of PVD 3. Describe PVD risk factor modification and treatment 4. Describe oral antiplatelet therapies 5. Identify when monotherapy vs. combination antiplatelet therapy is indicated with atherothrombosis
Estimated time to complete this activity is 38 minutes.
Physicians, diabetes educators, and other health care professionals who treat patients with diabetes.
Accreditation and Designation of Credit
PODIATRY: The Ohio College of Podiatric Medicine(OCPM) is an approved sponsor of Continuing Podiatric Medical Education through the Council on Podiatric Medical Education (CPME).
The Ohio College of Podiatric Medicine credits this activity for 0.75 credit hour.
Release Date:
01/22/2009
Expiration Date:
12/30/2012
Peer Review:
on 01/22/2009
A Pentium-III class computer with a minimum of 256MB of system RAM is required to view Online Internet lectures.
While a 56Kbps dial-up connection is supported, a Cable or DSL broadband Internet is strongly recommended for optimal video playback.
You will need an up-to-date web browser such as Internet Explorer, Mozilla Firefox,
or the AOL browser with Java and JavaScript enabled. Some lectures require the use of Internet Explorer to run and will not
run with other browsers. Lectures may require the use of helper applications or plug-ins to access the materials.
For example, most online lectures/presentations require either Adobe Flash Player or Windows Media Player (both free). To be able to print completion certificates Adobe Acrobat Reader must be installed.
It is the policy of PRESENT e-Learning Systems and it's accreditors to insure balance, independence,
objectivity and scientific rigor in all its individually sponsored or jointly sponsored educational programs.
All faculty participating in any PRESENT e-Learning Systems sponsored programs are expected to disclose to the
program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter
of the continuing education program. This pertains to relationships with pharmaceutical companies,
biomedical device manufacturers, or other corporations whose products or services are related to the
subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with
a potential conflict of interest from making a presentation. It is merely intended that any potential
conflict should be identified openly so that the listeners may form their own
judgments about the presentation with the full disclosure of the facts.